Australia markets open in 9 hours 10 minutes

Repligen Corporation (RGEN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
154.53-0.10 (-0.06%)
At close: 04:00PM EDT
154.53 0.00 (0.00%)
After hours: 05:20PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close154.63
Bid148.95 x 800
Ask157.50 x 800
Day's range150.09 - 158.00
52-week range137.21 - 327.32
Avg. volume511,583
Market cap8.566B
Beta (5Y monthly)0.98
PE ratio (TTM)61.10
EPS (TTM)2.53
Earnings date25 July 2022 - 29 July 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est239.88
  • Motley Fool

    2 Top Healthcare Stocks to Buy for the Long Haul

    Moderna (NASDAQ: MRNA) and Repligen (NASDAQ: RGEN) are two companies that have seen their stock prices decrease even as they posted positive business results. While Moderna may have been known to some investors prior to the pandemic, the biotech company has become a household name as it was able to bring to market its highly successful vaccine for COVID-19. Prior to this, Moderna had nothing commercially available, so the sales growth over the past year-plus is from a base of zero revenue.

  • Zacks

    Will Repligen's (RGEN) COVID Woes Be Offset by Product Demand?

    The declining pace of COVID-19 vaccination programs is likely to hurt Repligen's (RGEN) revenue growth rate in 2022. However, the strong core business is likely to offer a respite.

  • Simply Wall St.

    We Think Repligen (NASDAQ:RGEN) Can Manage Its Debt With Ease

    Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...